Concord Medical Services Holdings Limited (CCM) P/E Ratio History
Historical price-to-earnings valuation from 2013 to 2014
Loading P/E history...
CCM Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Concord Medical Services Holdings Limited (CCM) trades at a price-to-earnings ratio of -0.0x, with a stock price of $5.14 and trailing twelve-month earnings per share of $-1120.21.
The current P/E is 101% below its 5-year average of 1.2x. Over the past five years, CCM's P/E has ranged from a low of 0.8x to a high of 1.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, CCM trades at a 100% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, CCM trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CCM DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CCM P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $897M | 41.5 | - | -23% | |
| $569M | 12.3Lowest | - | -15% | |
| $161B | 57.6 | 2.65 | +23% | |
| $100B | 21.6 | - | +31%Best | |
| $48B | 45.2 | 6.39 | -74% | |
| $113B | 35.0 | 2.36 | +8% | |
| $96B | 15.1 | 0.72Best | +29% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
CCM Historical P/E Data (2013–2014)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2014 Q4 | Wed Dec 31 2014 00:00:00 GM | $64.10 | $78.00 | 0.8x | -29% |
| FY2013 Q4 | $48.14 | $32.40 | 1.5x | +29% |
Average P/E for displayed period: 1.2x
See CCM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CCM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCCM — Frequently Asked Questions
Quick answers to the most common questions about buying CCM stock.
Is CCM stock overvalued or undervalued?
CCM current P/E: -0.0x. 5-year average P/E: 1.2x. Percentile: N/A.
How does CCM's valuation compare to peers?
Concord Medical Services Holdings Limited P/E of -0.0x compares to sector median of 22.3x. Sector comparison provides relative valuation context.
What is CCM's PEG ratio?
CCM PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2013-2014.